UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of molecular sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2475
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Lymphoma | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites | Index Medicus | diffuse large B-cell lymphoma (DLBCL) | chronic lymphocytic leukemia (CLL) | burkitt lymphoma (BL) | gene regulation | circular RNA | acute lymphoblastic leukemia (ALL) | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM)
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | General aspects | Infectious diseases | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 12/2012, Volume 44, Issue 12, pp. 1321 - 1325
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Infectious diseases | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Genetics of eukaryotes. Biological and molecular evolution | Medical sciences | Translocation, Genetic | Glutamate Formimidoyltransferase - genetics | Ammonia-Lyases - genetics | Membrane Proteins - genetics | Humans | GTP-Binding Protein alpha Subunits, G12-G13 - genetics | Inhibitor of Differentiation Proteins - genetics | Molecular Sequence Data | Transcription Factors - genetics | Sequence Analysis, DNA | Homeodomain Proteins - genetics | Chaperonin Containing TCP-1 - genetics | Base Sequence | Genes, myc - genetics | Burkitt Lymphoma - genetics | Cell Line, Tumor | Mutation | Genome, Human | Neoplasm Proteins - genetics | Nuclear Proteins - genetics | DNA Helicases - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-ret - genetics | Usage | Gene mutations | Exome sequencing | Development and progression | Diagnosis | Research | Health aspects | Risk factors | Burkitt's lymphoma | Genetics | Lymphoma | Cancer | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Infectious diseases | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus | high-grade B-cell lymphoma | diffuse large B-cell lymphoma | cytogenetics
Journal Article
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 2988 - 2996
Life Sciences & Biomedicine | Hematology | Science & Technology | Chromatin - metabolism | Epigenesis, Genetic | Genomics | Humans | Lymphoma, Mantle-Cell - pathology | Gene Regulatory Networks | Tumor Suppressor Protein p53 - genetics | Burkitt Lymphoma - pathology | Telomere-Binding Proteins - genetics | Burkitt Lymphoma - genetics | Neoplasm Proteins - genetics | Nuclear Proteins - genetics | DNA Helicases - genetics | Lymphoma, Mantle-Cell - genetics | B-Lymphocytes - metabolism | Histone-Lysine N-Methyltransferase - genetics | Repressor Proteins - genetics | Germinal Center - pathology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Sequence Analysis, DNA | Exome - genetics | Germinal Center - metabolism | Histones - genetics | Cyclin D1 - genetics | Retinoblastoma Protein - genetics | Histones - metabolism | Mutation | Ataxia Telangiectasia Mutated Proteins - genetics | Methylation | Chromatin - genetics | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia
Journal Article